Assessment of the relationship between CD276 expression in tumor cells and clinical factors demonstrated its effect on lateral lymph node metastasis and postoperative serum CT levels, underscoring the need to identify effective therapies for patients with MTC and elevated CD276 protein levels. Here, CD276 is linked to neoplasm.